nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CCR5—rheumatoid arthritis	0.638	1	CbGaD
Maraviroc—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0243	0.206	CbGbCtD
Maraviroc—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0179	0.152	CbGbCtD
Maraviroc—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0136	0.115	CbGbCtD
Maraviroc—CYP3A4—Betamethasone—rheumatoid arthritis	0.0117	0.0989	CbGbCtD
Maraviroc—CYP3A4—Prednisolone—rheumatoid arthritis	0.0115	0.0976	CbGbCtD
Maraviroc—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0109	0.0925	CbGbCtD
Maraviroc—CYP3A4—Prednisone—rheumatoid arthritis	0.0109	0.0922	CbGbCtD
Maraviroc—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0103	0.0874	CbGbCtD
Maraviroc—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00678	0.0575	CbGbCtD
Maraviroc—CCR5—connective tissue—rheumatoid arthritis	0.000868	0.396	CbGeAlD
Maraviroc—CCR5—lymphoid tissue—rheumatoid arthritis	0.000635	0.289	CbGeAlD
Maraviroc—CCR5—digestive system—rheumatoid arthritis	0.000627	0.286	CbGeAlD
Maraviroc—CCR5—Peptide ligand-binding receptors—CX3CR1—rheumatoid arthritis	0.000548	0.00551	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—NOS2—rheumatoid arthritis	0.000544	0.00547	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL6—rheumatoid arthritis	0.000533	0.00535	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CCL2—rheumatoid arthritis	0.000519	0.00521	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL13—rheumatoid arthritis	0.000519	0.00521	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL1A—rheumatoid arthritis	0.000516	0.00519	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—C5—rheumatoid arthritis	0.000509	0.00512	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL21—rheumatoid arthritis	0.000508	0.00511	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—CD8A—rheumatoid arthritis	0.000507	0.0051	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCR6—rheumatoid arthritis	0.000479	0.00481	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—FAS—rheumatoid arthritis	0.00046	0.00462	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—TYK2—rheumatoid arthritis	0.000446	0.00448	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL3—rheumatoid arthritis	0.000438	0.0044	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL2—rheumatoid arthritis	0.000438	0.0044	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—C5—rheumatoid arthritis	0.00043	0.00432	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CX3CR1—rheumatoid arthritis	0.000429	0.00431	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—SAA1—rheumatoid arthritis	0.000428	0.0043	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IFNG—rheumatoid arthritis	0.000417	0.00419	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL13—rheumatoid arthritis	0.000412	0.00414	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CXCL8—rheumatoid arthritis	0.00041	0.00412	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CCR6—rheumatoid arthritis	0.000404	0.00406	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—CD4—rheumatoid arthritis	0.000403	0.00405	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CCR6—rheumatoid arthritis	0.000375	0.00377	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL12—rheumatoid arthritis	0.000372	0.00374	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—BDKRB2—rheumatoid arthritis	0.000372	0.00374	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL1B—rheumatoid arthritis	0.000372	0.00374	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL2—rheumatoid arthritis	0.000371	0.00373	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL2—rheumatoid arthritis	0.00037	0.00371	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CX3CR1—rheumatoid arthritis	0.000368	0.00369	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—CD28—rheumatoid arthritis	0.000364	0.00366	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—SAA1—rheumatoid arthritis	0.000361	0.00363	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—NFKB1—rheumatoid arthritis	0.000347	0.00349	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—C5—rheumatoid arthritis	0.000342	0.00343	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL10—rheumatoid arthritis	0.000329	0.00331	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCR6—rheumatoid arthritis	0.000321	0.00323	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL12—rheumatoid arthritis	0.000314	0.00316	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—BDKRB2—rheumatoid arthritis	0.000314	0.00316	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL13—rheumatoid arthritis	0.000314	0.00316	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL6—rheumatoid arthritis	0.000301	0.00303	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL2—rheumatoid arthritis	0.000294	0.00295	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL3—rheumatoid arthritis	0.000294	0.00295	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—BDKRB2—rheumatoid arthritis	0.000292	0.00293	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—CD4—rheumatoid arthritis	0.000291	0.00293	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—SAA1—rheumatoid arthritis	0.000287	0.00289	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCL21—rheumatoid arthritis	0.000287	0.00289	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL5—rheumatoid arthritis	0.000283	0.00285	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CX3CR1—rheumatoid arthritis	0.00028	0.00281	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL10—rheumatoid arthritis	0.000278	0.00279	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL6—rheumatoid arthritis	0.000273	0.00275	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL1B—rheumatoid arthritis	0.000269	0.0027	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL21—rheumatoid arthritis	0.000261	0.00262	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—C5—rheumatoid arthritis	0.00026	0.00261	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—NFKB1—rheumatoid arthritis	0.000251	0.00252	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL12—rheumatoid arthritis	0.00025	0.00251	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—BDKRB2—rheumatoid arthritis	0.00025	0.00251	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—C3—rheumatoid arthritis	0.000249	0.00251	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—MAPK8—rheumatoid arthritis	0.000247	0.00248	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCR6—rheumatoid arthritis	0.000245	0.00246	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CCL5—rheumatoid arthritis	0.000239	0.0024	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PDE2A—rheumatoid arthritis	0.000228	0.00229	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—HLA-A—rheumatoid arthritis	0.000225	0.00226	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL3—rheumatoid arthritis	0.000224	0.00225	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL2—rheumatoid arthritis	0.000224	0.00225	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL10—rheumatoid arthritis	0.000221	0.00222	CbGpPWpGaD
Maraviroc—CCR5—Disease—SYVN1—rheumatoid arthritis	0.00022	0.00221	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—SAA1—rheumatoid arthritis	0.000219	0.0022	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—C3—rheumatoid arthritis	0.00021	0.00211	CbGpPWpGaD
Maraviroc—CCR5—HIV Life Cycle—CD4—rheumatoid arthritis	0.000209	0.0021	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—TGFB1—rheumatoid arthritis	0.000209	0.0021	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PDE2A—rheumatoid arthritis	0.000207	0.00208	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—POMC—rheumatoid arthritis	0.0002	0.002	CbGpPWpGaD
Maraviroc—CCR5—Disease—ACAN—rheumatoid arthritis	0.000196	0.00197	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL2—rheumatoid arthritis	0.000195	0.00196	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—BDKRB2—rheumatoid arthritis	0.00019	0.00191	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL12—rheumatoid arthritis	0.00019	0.00191	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL5—rheumatoid arthritis	0.00019	0.00191	CbGpPWpGaD
Maraviroc—CCR5—Disease—SLC25A12—rheumatoid arthritis	0.000184	0.00185	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL13—rheumatoid arthritis	0.000177	0.00178	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—POMC—rheumatoid arthritis	0.000168	0.00169	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL10—rheumatoid arthritis	0.000168	0.00169	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—C3—rheumatoid arthritis	0.000167	0.00168	CbGpPWpGaD
Maraviroc—CCR5—Disease—PLB1—rheumatoid arthritis	0.000167	0.00168	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL6—rheumatoid arthritis	0.000162	0.00162	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL13—rheumatoid arthritis	0.000161	0.00162	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL6—rheumatoid arthritis	0.000158	0.00158	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL8—rheumatoid arthritis	0.000154	0.00155	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SYVN1—rheumatoid arthritis	0.000154	0.00155	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL21—rheumatoid arthritis	0.000154	0.00155	CbGpPWpGaD
Maraviroc—CCR5—Disease—RBPJ—rheumatoid arthritis	0.000154	0.00155	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL2RB—rheumatoid arthritis	0.000152	0.00153	CbGpPWpGaD
Maraviroc—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—rheumatoid arthritis	0.000149	0.0015	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TAGAP—rheumatoid arthritis	0.000148	0.00148	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—C5—rheumatoid arthritis	0.000147	0.00148	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL5—rheumatoid arthritis	0.000145	0.00145	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—CD4—rheumatoid arthritis	0.000145	0.00145	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.000144	0.00144	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.000138	0.00139	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCR6—rheumatoid arthritis	0.000138	0.00139	CbGpPWpGaD
Maraviroc—CCR5—Disease—B3GNT2—rheumatoid arthritis	0.000136	0.00137	CbGpPWpGaD
Maraviroc—CCR5—Disease—ACP5—rheumatoid arthritis	0.000136	0.00137	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	0.000134	0.00134	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—C5—rheumatoid arthritis	0.000134	0.00134	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	0.000131	0.00132	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL8—rheumatoid arthritis	0.00013	0.00131	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—C3—rheumatoid arthritis	0.000127	0.00128	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL2—rheumatoid arthritis	0.000126	0.00127	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCR6—rheumatoid arthritis	0.000126	0.00126	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—SAA1—rheumatoid arthritis	0.000124	0.00124	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDE2A—rheumatoid arthritis	0.000122	0.00123	CbGpPWpGaD
Maraviroc—CCR5—Disease—TLE3—rheumatoid arthritis	0.000122	0.00123	CbGpPWpGaD
Maraviroc—CCR5—Disease—BGN—rheumatoid arthritis	0.000122	0.00123	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PLB1—rheumatoid arthritis	0.000117	0.00117	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL2—rheumatoid arthritis	0.000115	0.00115	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL3—rheumatoid arthritis	0.000115	0.00115	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—SAA1—rheumatoid arthritis	0.000112	0.00113	CbGpPWpGaD
Maraviroc—CCR5—Disease—SLC11A1—rheumatoid arthritis	0.000112	0.00112	CbGpPWpGaD
Maraviroc—CCR5—Disease—NFATC1—rheumatoid arthritis	0.000111	0.00111	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RBPJ—rheumatoid arthritis	0.000108	0.00108	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.000108	0.00108	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	0.000108	0.00108	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.000106	0.00107	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	0.000104	0.00104	CbGpPWpGaD
Maraviroc—CCR5—Disease—NCF2—rheumatoid arthritis	0.000103	0.00104	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—POMC—rheumatoid arthritis	0.000102	0.00102	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	0.0001	0.00101	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL2—rheumatoid arthritis	9.97e-05	0.001	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	9.81e-05	0.000986	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL12—rheumatoid arthritis	9.76e-05	0.000981	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—BDKRB2—rheumatoid arthritis	9.76e-05	0.000981	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—ADRBK1—rheumatoid arthritis	9.65e-05	0.00097	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL13—rheumatoid arthritis	9.52e-05	0.000957	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL10—rheumatoid arthritis	9.5e-05	0.000955	CbGpPWpGaD
Maraviroc—CCR5—Disease—SAA1—rheumatoid arthritis	9.47e-05	0.000952	CbGpPWpGaD
Maraviroc—CCR5—Disease—NCF1—rheumatoid arthritis	9.28e-05	0.000932	CbGpPWpGaD
Maraviroc—CCR5—Disease—ENO1—rheumatoid arthritis	9.18e-05	0.000923	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—RASGRP1—rheumatoid arthritis	9.11e-05	0.000915	CbGpPWpGaD
Maraviroc—CCR5—Disease—CD28—rheumatoid arthritis	8.92e-05	0.000896	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PRKCQ—rheumatoid arthritis	8.91e-05	0.000895	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL10—rheumatoid arthritis	8.63e-05	0.000867	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TLE3—rheumatoid arthritis	8.57e-05	0.000861	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IRAK1—rheumatoid arthritis	8.57e-05	0.000861	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	8.57e-05	0.000861	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CX3CR1—rheumatoid arthritis	8.48e-05	0.000853	CbGpPWpGaD
Maraviroc—CCR5—Disease—UBE2D1—rheumatoid arthritis	8.4e-05	0.000844	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCL5—rheumatoid arthritis	8.18e-05	0.000822	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL2RB—rheumatoid arthritis	8.17e-05	0.000821	CbGpPWpGaD
Maraviroc—CCR5—Disease—ADRBK1—rheumatoid arthritis	8.14e-05	0.000818	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CSF2—rheumatoid arthritis	8.06e-05	0.00081	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—C5—rheumatoid arthritis	7.89e-05	0.000793	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL8—rheumatoid arthritis	7.88e-05	0.000792	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—MMP3—rheumatoid arthritis	7.87e-05	0.000791	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NFATC1—rheumatoid arthritis	7.76e-05	0.00078	CbGpPWpGaD
Maraviroc—CCR5—Disease—PRKCQ—rheumatoid arthritis	7.52e-05	0.000755	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL5—rheumatoid arthritis	7.43e-05	0.000746	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCR6—rheumatoid arthritis	7.42e-05	0.000745	CbGpPWpGaD
Maraviroc—CCR5—Disease—STAT1—rheumatoid arthritis	7.38e-05	0.000742	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CSF2—rheumatoid arthritis	7.32e-05	0.000735	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL2RA—rheumatoid arthritis	7.26e-05	0.00073	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NCF2—rheumatoid arthritis	7.21e-05	0.000725	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—C3—rheumatoid arthritis	7.2e-05	0.000724	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TRAF6—rheumatoid arthritis	7.03e-05	0.000706	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SH2B3—rheumatoid arthritis	7.03e-05	0.000706	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GZMB—rheumatoid arthritis	6.99e-05	0.000702	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—CAT—rheumatoid arthritis	6.93e-05	0.000696	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL2—rheumatoid arthritis	6.78e-05	0.000682	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL3—rheumatoid arthritis	6.78e-05	0.000682	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SAA1—rheumatoid arthritis	6.63e-05	0.000667	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL2RA—rheumatoid arthritis	6.59e-05	0.000663	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—C3—rheumatoid arthritis	6.54e-05	0.000657	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NCF1—rheumatoid arthritis	6.5e-05	0.000653	CbGpPWpGaD
Maraviroc—CYP3A4—digestive system—rheumatoid arthritis	6.32e-05	0.0288	CbGeAlD
Maraviroc—CCR5—Signaling Pathways—CD28—rheumatoid arthritis	6.25e-05	0.000628	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—UBE2D1—rheumatoid arthritis	5.88e-05	0.000591	CbGpPWpGaD
Maraviroc—Anxiety—Methylprednisolone—rheumatoid arthritis	5.86e-05	0.000411	CcSEcCtD
Maraviroc—Infestation NOS—Methotrexate—rheumatoid arthritis	5.85e-05	0.00041	CcSEcCtD
Maraviroc—Infestation—Methotrexate—rheumatoid arthritis	5.85e-05	0.00041	CcSEcCtD
Maraviroc—Rash—Azathioprine—rheumatoid arthritis	5.84e-05	0.00041	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	5.84e-05	0.00041	CcSEcCtD
Maraviroc—Dermatitis—Azathioprine—rheumatoid arthritis	5.84e-05	0.000409	CcSEcCtD
Maraviroc—Depression—Methotrexate—rheumatoid arthritis	5.84e-05	0.000409	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	5.83e-05	0.000409	CcSEcCtD
Maraviroc—Skin disorder—Hydrocortisone—rheumatoid arthritis	5.83e-05	0.000409	CcSEcCtD
Maraviroc—Discomfort—Triamcinolone—rheumatoid arthritis	5.83e-05	0.000408	CcSEcCtD
Maraviroc—Fatigue—Cyclosporine—rheumatoid arthritis	5.82e-05	0.000408	CcSEcCtD
Maraviroc—Discomfort—Methylprednisolone—rheumatoid arthritis	5.81e-05	0.000407	CcSEcCtD
Maraviroc—Headache—Azathioprine—rheumatoid arthritis	5.81e-05	0.000407	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Methotrexate—rheumatoid arthritis	5.8e-05	0.000407	CcSEcCtD
Maraviroc—Dizziness—Leflunomide—rheumatoid arthritis	5.79e-05	0.000406	CcSEcCtD
Maraviroc—Constipation—Cyclosporine—rheumatoid arthritis	5.78e-05	0.000405	CcSEcCtD
Maraviroc—Pain—Cyclosporine—rheumatoid arthritis	5.78e-05	0.000405	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—BDKRB2—rheumatoid arthritis	5.77e-05	0.00058	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL12—rheumatoid arthritis	5.77e-05	0.00058	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—POMC—rheumatoid arthritis	5.76e-05	0.000579	CbGpPWpGaD
Maraviroc—Renal failure—Methotrexate—rheumatoid arthritis	5.75e-05	0.000403	CcSEcCtD
Maraviroc—Anorexia—Hydrocortisone—rheumatoid arthritis	5.72e-05	0.000401	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL6ST—rheumatoid arthritis	5.72e-05	0.000575	CbGpPWpGaD
Maraviroc—Stomatitis—Methotrexate—rheumatoid arthritis	5.71e-05	0.0004	CcSEcCtD
Maraviroc—Angiopathy—Prednisone—rheumatoid arthritis	5.7e-05	0.0004	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ADRBK1—rheumatoid arthritis	5.7e-05	0.000573	CbGpPWpGaD
Maraviroc—Conjunctivitis—Methotrexate—rheumatoid arthritis	5.69e-05	0.000399	CcSEcCtD
Maraviroc—Oedema—Triamcinolone—rheumatoid arthritis	5.65e-05	0.000396	CcSEcCtD
Maraviroc—Syncope—Dexamethasone—rheumatoid arthritis	5.64e-05	0.000395	CcSEcCtD
Maraviroc—Syncope—Betamethasone—rheumatoid arthritis	5.64e-05	0.000395	CcSEcCtD
Maraviroc—Infection—Triamcinolone—rheumatoid arthritis	5.62e-05	0.000394	CcSEcCtD
Maraviroc—Infection—Methylprednisolone—rheumatoid arthritis	5.6e-05	0.000393	CcSEcCtD
Maraviroc—Vomiting—Leflunomide—rheumatoid arthritis	5.57e-05	0.00039	CcSEcCtD
Maraviroc—Shock—Triamcinolone—rheumatoid arthritis	5.56e-05	0.00039	CcSEcCtD
Maraviroc—Insomnia—Prednisolone—rheumatoid arthritis	5.56e-05	0.00039	CcSEcCtD
Maraviroc—Alopecia—Prednisone—rheumatoid arthritis	5.56e-05	0.000389	CcSEcCtD
Maraviroc—Shock—Methylprednisolone—rheumatoid arthritis	5.55e-05	0.000389	CcSEcCtD
Maraviroc—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	5.54e-05	0.000388	CcSEcCtD
Maraviroc—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	5.53e-05	0.000388	CcSEcCtD
Maraviroc—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	5.52e-05	0.000387	CcSEcCtD
Maraviroc—Loss of consciousness—Betamethasone—rheumatoid arthritis	5.52e-05	0.000387	CcSEcCtD
Maraviroc—Loss of consciousness—Dexamethasone—rheumatoid arthritis	5.52e-05	0.000387	CcSEcCtD
Maraviroc—Paraesthesia—Prednisolone—rheumatoid arthritis	5.52e-05	0.000387	CcSEcCtD
Maraviroc—Rash—Leflunomide—rheumatoid arthritis	5.52e-05	0.000387	CcSEcCtD
Maraviroc—CCR5—Disease—MTHFR—rheumatoid arthritis	5.52e-05	0.000554	CbGpPWpGaD
Maraviroc—Dermatitis—Leflunomide—rheumatoid arthritis	5.51e-05	0.000386	CcSEcCtD
Maraviroc—Mental disorder—Prednisone—rheumatoid arthritis	5.51e-05	0.000386	CcSEcCtD
Maraviroc—Nausea—Azathioprine—rheumatoid arthritis	5.51e-05	0.000386	CcSEcCtD
Maraviroc—CCR5—Disease—HLA-A—rheumatoid arthritis	5.5e-05	0.000553	CbGpPWpGaD
Maraviroc—Headache—Leflunomide—rheumatoid arthritis	5.48e-05	0.000384	CcSEcCtD
Maraviroc—Skin disorder—Methylprednisolone—rheumatoid arthritis	5.48e-05	0.000384	CcSEcCtD
Maraviroc—Erythema—Prednisone—rheumatoid arthritis	5.47e-05	0.000384	CcSEcCtD
Maraviroc—Malnutrition—Prednisone—rheumatoid arthritis	5.47e-05	0.000384	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	5.47e-05	0.000383	CcSEcCtD
Maraviroc—Agranulocytosis—Methotrexate—rheumatoid arthritis	5.46e-05	0.000383	CcSEcCtD
Maraviroc—Convulsion—Dexamethasone—rheumatoid arthritis	5.45e-05	0.000382	CcSEcCtD
Maraviroc—Convulsion—Betamethasone—rheumatoid arthritis	5.45e-05	0.000382	CcSEcCtD
Maraviroc—Insomnia—Hydrocortisone—rheumatoid arthritis	5.43e-05	0.000381	CcSEcCtD
Maraviroc—Paraesthesia—Hydrocortisone—rheumatoid arthritis	5.39e-05	0.000378	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.38e-05	0.000541	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SYK—rheumatoid arthritis	5.36e-05	0.000539	CbGpPWpGaD
Maraviroc—Myalgia—Betamethasone—rheumatoid arthritis	5.35e-05	0.000375	CcSEcCtD
Maraviroc—Myalgia—Dexamethasone—rheumatoid arthritis	5.35e-05	0.000375	CcSEcCtD
Maraviroc—Abdominal pain—Cyclosporine—rheumatoid arthritis	5.34e-05	0.000374	CcSEcCtD
Maraviroc—Body temperature increased—Cyclosporine—rheumatoid arthritis	5.34e-05	0.000374	CcSEcCtD
Maraviroc—Anxiety—Dexamethasone—rheumatoid arthritis	5.33e-05	0.000374	CcSEcCtD
Maraviroc—Anxiety—Betamethasone—rheumatoid arthritis	5.33e-05	0.000374	CcSEcCtD
Maraviroc—Discomfort—Dexamethasone—rheumatoid arthritis	5.29e-05	0.000371	CcSEcCtD
Maraviroc—Discomfort—Betamethasone—rheumatoid arthritis	5.29e-05	0.000371	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.26e-05	0.000529	CbGpPWpGaD
Maraviroc—Pain—Prednisolone—rheumatoid arthritis	5.26e-05	0.000368	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—POMC—rheumatoid arthritis	5.23e-05	0.000526	CbGpPWpGaD
Maraviroc—Decreased appetite—Hydrocortisone—rheumatoid arthritis	5.22e-05	0.000366	CcSEcCtD
Maraviroc—Pharyngitis—Methotrexate—rheumatoid arthritis	5.22e-05	0.000366	CcSEcCtD
Maraviroc—Nausea—Leflunomide—rheumatoid arthritis	5.2e-05	0.000364	CcSEcCtD
Maraviroc—Urinary tract disorder—Methotrexate—rheumatoid arthritis	5.19e-05	0.000364	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	5.18e-05	0.000363	CcSEcCtD
Maraviroc—Fatigue—Hydrocortisone—rheumatoid arthritis	5.18e-05	0.000363	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—STAT1—rheumatoid arthritis	5.17e-05	0.00052	CbGpPWpGaD
Maraviroc—Urethral disorder—Methotrexate—rheumatoid arthritis	5.15e-05	0.000361	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	5.15e-05	0.000361	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	5.14e-05	0.00036	CcSEcCtD
Maraviroc—Pain—Hydrocortisone—rheumatoid arthritis	5.13e-05	0.00036	CcSEcCtD
Maraviroc—Oedema—Dexamethasone—rheumatoid arthritis	5.13e-05	0.00036	CcSEcCtD
Maraviroc—Oedema—Betamethasone—rheumatoid arthritis	5.13e-05	0.00036	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CCL2—rheumatoid arthritis	5.12e-05	0.000514	CbGpPWpGaD
Maraviroc—Insomnia—Triamcinolone—rheumatoid arthritis	5.11e-05	0.000358	CcSEcCtD
Maraviroc—Insomnia—Methylprednisolone—rheumatoid arthritis	5.1e-05	0.000358	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL6R—rheumatoid arthritis	5.1e-05	0.000513	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL10—rheumatoid arthritis	5.1e-05	0.000512	CbGpPWpGaD
Maraviroc—Infection—Dexamethasone—rheumatoid arthritis	5.1e-05	0.000357	CcSEcCtD
Maraviroc—Infection—Betamethasone—rheumatoid arthritis	5.1e-05	0.000357	CcSEcCtD
Maraviroc—Paraesthesia—Triamcinolone—rheumatoid arthritis	5.08e-05	0.000356	CcSEcCtD
Maraviroc—Paraesthesia—Methylprednisolone—rheumatoid arthritis	5.06e-05	0.000355	CcSEcCtD
Maraviroc—Anaemia—Prednisone—rheumatoid arthritis	5.06e-05	0.000355	CcSEcCtD
Maraviroc—Shock—Dexamethasone—rheumatoid arthritis	5.05e-05	0.000354	CcSEcCtD
Maraviroc—Shock—Betamethasone—rheumatoid arthritis	5.05e-05	0.000354	CcSEcCtD
Maraviroc—Nervous system disorder—Betamethasone—rheumatoid arthritis	5.03e-05	0.000353	CcSEcCtD
Maraviroc—Nervous system disorder—Dexamethasone—rheumatoid arthritis	5.03e-05	0.000353	CcSEcCtD
Maraviroc—Hypersensitivity—Cyclosporine—rheumatoid arthritis	4.98e-05	0.000349	CcSEcCtD
Maraviroc—Erythema multiforme—Methotrexate—rheumatoid arthritis	4.97e-05	0.000348	CcSEcCtD
Maraviroc—Eye disorder—Methotrexate—rheumatoid arthritis	4.91e-05	0.000344	CcSEcCtD
Maraviroc—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	4.91e-05	0.000344	CcSEcCtD
Maraviroc—Syncope—Prednisone—rheumatoid arthritis	4.91e-05	0.000344	CcSEcCtD
Maraviroc—Anorexia—Betamethasone—rheumatoid arthritis	4.89e-05	0.000343	CcSEcCtD
Maraviroc—Anorexia—Dexamethasone—rheumatoid arthritis	4.89e-05	0.000343	CcSEcCtD
Maraviroc—Cardiac disorder—Methotrexate—rheumatoid arthritis	4.88e-05	0.000342	CcSEcCtD
Maraviroc—Fatigue—Triamcinolone—rheumatoid arthritis	4.87e-05	0.000342	CcSEcCtD
Maraviroc—Fatigue—Methylprednisolone—rheumatoid arthritis	4.86e-05	0.000341	CcSEcCtD
Maraviroc—Asthenia—Cyclosporine—rheumatoid arthritis	4.85e-05	0.00034	CcSEcCtD
Maraviroc—Pain—Triamcinolone—rheumatoid arthritis	4.83e-05	0.000339	CcSEcCtD
Maraviroc—CCR5—Disease—IL6ST—rheumatoid arthritis	4.82e-05	0.000485	CbGpPWpGaD
Maraviroc—Loss of consciousness—Prednisone—rheumatoid arthritis	4.81e-05	0.000337	CcSEcCtD
Maraviroc—CCR5—Disease—NOS2—rheumatoid arthritis	4.79e-05	0.000481	CbGpPWpGaD
Maraviroc—Pruritus—Cyclosporine—rheumatoid arthritis	4.78e-05	0.000335	CcSEcCtD
Maraviroc—Angiopathy—Methotrexate—rheumatoid arthritis	4.77e-05	0.000334	CcSEcCtD
Maraviroc—Body temperature increased—Hydrocortisone—rheumatoid arthritis	4.75e-05	0.000333	CcSEcCtD
Maraviroc—Abdominal pain—Hydrocortisone—rheumatoid arthritis	4.75e-05	0.000333	CcSEcCtD
Maraviroc—Convulsion—Prednisone—rheumatoid arthritis	4.74e-05	0.000332	CcSEcCtD
Maraviroc—Mediastinal disorder—Methotrexate—rheumatoid arthritis	4.74e-05	0.000332	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	4.67e-05	0.000328	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	4.67e-05	0.000328	CcSEcCtD
Maraviroc—Myalgia—Prednisone—rheumatoid arthritis	4.66e-05	0.000327	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—MMP3—rheumatoid arthritis	4.65e-05	0.000467	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—TYK2—rheumatoid arthritis	4.65e-05	0.000467	CbGpPWpGaD
Maraviroc—Anxiety—Prednisone—rheumatoid arthritis	4.64e-05	0.000325	CcSEcCtD
Maraviroc—Alopecia—Methotrexate—rheumatoid arthritis	4.64e-05	0.000325	CcSEcCtD
Maraviroc—CCR5—Disease—CD80—rheumatoid arthritis	4.64e-05	0.000467	CbGpPWpGaD
Maraviroc—Insomnia—Betamethasone—rheumatoid arthritis	4.64e-05	0.000325	CcSEcCtD
Maraviroc—Insomnia—Dexamethasone—rheumatoid arthritis	4.64e-05	0.000325	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	4.63e-05	0.000324	CcSEcCtD
Maraviroc—Diarrhoea—Cyclosporine—rheumatoid arthritis	4.62e-05	0.000324	CcSEcCtD
Maraviroc—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	4.61e-05	0.000323	CcSEcCtD
Maraviroc—Paraesthesia—Dexamethasone—rheumatoid arthritis	4.61e-05	0.000323	CcSEcCtD
Maraviroc—Paraesthesia—Betamethasone—rheumatoid arthritis	4.61e-05	0.000323	CcSEcCtD
Maraviroc—Discomfort—Prednisone—rheumatoid arthritis	4.6e-05	0.000323	CcSEcCtD
Maraviroc—Mental disorder—Methotrexate—rheumatoid arthritis	4.6e-05	0.000323	CcSEcCtD
Maraviroc—Malnutrition—Methotrexate—rheumatoid arthritis	4.57e-05	0.000321	CcSEcCtD
Maraviroc—Erythema—Methotrexate—rheumatoid arthritis	4.57e-05	0.000321	CcSEcCtD
Maraviroc—Hypersensitivity—Prednisolone—rheumatoid arthritis	4.53e-05	0.000317	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PTK2—rheumatoid arthritis	4.47e-05	0.00045	CbGpPWpGaD
Maraviroc—Body temperature increased—Triamcinolone—rheumatoid arthritis	4.47e-05	0.000313	CcSEcCtD
Maraviroc—Dizziness—Cyclosporine—rheumatoid arthritis	4.47e-05	0.000313	CcSEcCtD
Maraviroc—Oedema—Prednisone—rheumatoid arthritis	4.47e-05	0.000313	CcSEcCtD
Maraviroc—Abdominal pain—Methylprednisolone—rheumatoid arthritis	4.46e-05	0.000313	CcSEcCtD
Maraviroc—Decreased appetite—Betamethasone—rheumatoid arthritis	4.46e-05	0.000313	CcSEcCtD
Maraviroc—Decreased appetite—Dexamethasone—rheumatoid arthritis	4.46e-05	0.000313	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—CXCL8—rheumatoid arthritis	4.45e-05	0.000448	CbGpPWpGaD
Maraviroc—Infection—Prednisone—rheumatoid arthritis	4.44e-05	0.000311	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	4.43e-05	0.00031	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	4.43e-05	0.00031	CcSEcCtD
Maraviroc—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	4.42e-05	0.00031	CcSEcCtD
Maraviroc—Fatigue—Betamethasone—rheumatoid arthritis	4.42e-05	0.00031	CcSEcCtD
Maraviroc—Fatigue—Dexamethasone—rheumatoid arthritis	4.42e-05	0.00031	CcSEcCtD
Maraviroc—Shock—Prednisone—rheumatoid arthritis	4.39e-05	0.000308	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CCL5—rheumatoid arthritis	4.39e-05	0.000441	CbGpPWpGaD
Maraviroc—Pain—Betamethasone—rheumatoid arthritis	4.39e-05	0.000307	CcSEcCtD
Maraviroc—Pain—Dexamethasone—rheumatoid arthritis	4.39e-05	0.000307	CcSEcCtD
Maraviroc—Nervous system disorder—Prednisone—rheumatoid arthritis	4.38e-05	0.000307	CcSEcCtD
Maraviroc—Skin disorder—Prednisone—rheumatoid arthritis	4.34e-05	0.000304	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CSF2—rheumatoid arthritis	4.32e-05	0.000434	CbGpPWpGaD
Maraviroc—Asthenia—Hydrocortisone—rheumatoid arthritis	4.31e-05	0.000302	CcSEcCtD
Maraviroc—CCR5—Disease—IL6R—rheumatoid arthritis	4.3e-05	0.000432	CbGpPWpGaD
Maraviroc—Vomiting—Cyclosporine—rheumatoid arthritis	4.3e-05	0.000301	CcSEcCtD
Maraviroc—Rash—Cyclosporine—rheumatoid arthritis	4.26e-05	0.000299	CcSEcCtD
Maraviroc—Anorexia—Prednisone—rheumatoid arthritis	4.26e-05	0.000298	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—IL2—rheumatoid arthritis	4.26e-05	0.000428	CbGpPWpGaD
Maraviroc—Dermatitis—Cyclosporine—rheumatoid arthritis	4.26e-05	0.000298	CcSEcCtD
Maraviroc—Pruritus—Hydrocortisone—rheumatoid arthritis	4.25e-05	0.000298	CcSEcCtD
Maraviroc—Headache—Cyclosporine—rheumatoid arthritis	4.23e-05	0.000297	CcSEcCtD
Maraviroc—Anaemia—Methotrexate—rheumatoid arthritis	4.23e-05	0.000296	CcSEcCtD
Maraviroc—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	4.19e-05	0.000294	CcSEcCtD
Maraviroc—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	4.19e-05	0.000294	CcSEcCtD
Maraviroc—Hypersensitivity—Triamcinolone—rheumatoid arthritis	4.17e-05	0.000292	CcSEcCtD
Maraviroc—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	4.16e-05	0.000291	CcSEcCtD
Maraviroc—Diarrhoea—Hydrocortisone—rheumatoid arthritis	4.11e-05	0.000288	CcSEcCtD
Maraviroc—Leukopenia—Methotrexate—rheumatoid arthritis	4.09e-05	0.000287	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	4.07e-05	0.000285	CcSEcCtD
Maraviroc—Dizziness—Prednisolone—rheumatoid arthritis	4.07e-05	0.000285	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—SPP1—rheumatoid arthritis	4.06e-05	0.000408	CbGpPWpGaD
Maraviroc—Asthenia—Triamcinolone—rheumatoid arthritis	4.06e-05	0.000284	CcSEcCtD
Maraviroc—Body temperature increased—Dexamethasone—rheumatoid arthritis	4.05e-05	0.000284	CcSEcCtD
Maraviroc—Abdominal pain—Betamethasone—rheumatoid arthritis	4.05e-05	0.000284	CcSEcCtD
Maraviroc—Abdominal pain—Dexamethasone—rheumatoid arthritis	4.05e-05	0.000284	CcSEcCtD
Maraviroc—Body temperature increased—Betamethasone—rheumatoid arthritis	4.05e-05	0.000284	CcSEcCtD
Maraviroc—Asthenia—Methylprednisolone—rheumatoid arthritis	4.05e-05	0.000284	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.05e-05	0.000407	CbGpPWpGaD
Maraviroc—Insomnia—Prednisone—rheumatoid arthritis	4.04e-05	0.000283	CcSEcCtD
Maraviroc—Nausea—Cyclosporine—rheumatoid arthritis	4.01e-05	0.000281	CcSEcCtD
Maraviroc—Paraesthesia—Prednisone—rheumatoid arthritis	4.01e-05	0.000281	CcSEcCtD
Maraviroc—Pruritus—Triamcinolone—rheumatoid arthritis	4e-05	0.00028	CcSEcCtD
Maraviroc—Cough—Methotrexate—rheumatoid arthritis	3.99e-05	0.00028	CcSEcCtD
Maraviroc—Pruritus—Methylprednisolone—rheumatoid arthritis	3.99e-05	0.00028	CcSEcCtD
Maraviroc—Dizziness—Hydrocortisone—rheumatoid arthritis	3.97e-05	0.000278	CcSEcCtD
Maraviroc—Convulsion—Methotrexate—rheumatoid arthritis	3.96e-05	0.000278	CcSEcCtD
Maraviroc—CCR5—Disease—TYK2—rheumatoid arthritis	3.92e-05	0.000394	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL2RA—rheumatoid arthritis	3.9e-05	0.000391	CbGpPWpGaD
Maraviroc—Myalgia—Methotrexate—rheumatoid arthritis	3.89e-05	0.000273	CcSEcCtD
Maraviroc—Decreased appetite—Prednisone—rheumatoid arthritis	3.88e-05	0.000272	CcSEcCtD
Maraviroc—Rash—Prednisolone—rheumatoid arthritis	3.88e-05	0.000272	CcSEcCtD
Maraviroc—Dermatitis—Prednisolone—rheumatoid arthritis	3.87e-05	0.000271	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	3.87e-05	0.000271	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL2—rheumatoid arthritis	3.87e-05	0.000389	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—C3—rheumatoid arthritis	3.86e-05	0.000388	CbGpPWpGaD
Maraviroc—Diarrhoea—Methylprednisolone—rheumatoid arthritis	3.86e-05	0.00027	CcSEcCtD
Maraviroc—Fatigue—Prednisone—rheumatoid arthritis	3.85e-05	0.00027	CcSEcCtD
Maraviroc—Headache—Prednisolone—rheumatoid arthritis	3.85e-05	0.00027	CcSEcCtD
Maraviroc—Discomfort—Methotrexate—rheumatoid arthritis	3.85e-05	0.00027	CcSEcCtD
Maraviroc—CCR5—Disease—NOS3—rheumatoid arthritis	3.85e-05	0.000387	CbGpPWpGaD
Maraviroc—Constipation—Prednisone—rheumatoid arthritis	3.82e-05	0.000268	CcSEcCtD
Maraviroc—Vomiting—Hydrocortisone—rheumatoid arthritis	3.82e-05	0.000268	CcSEcCtD
Maraviroc—Rash—Hydrocortisone—rheumatoid arthritis	3.79e-05	0.000265	CcSEcCtD
Maraviroc—Dermatitis—Hydrocortisone—rheumatoid arthritis	3.78e-05	0.000265	CcSEcCtD
Maraviroc—Headache—Hydrocortisone—rheumatoid arthritis	3.76e-05	0.000264	CcSEcCtD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	3.74e-05	0.000376	CbGpPWpGaD
Maraviroc—Dizziness—Triamcinolone—rheumatoid arthritis	3.74e-05	0.000262	CcSEcCtD
Maraviroc—Dizziness—Methylprednisolone—rheumatoid arthritis	3.73e-05	0.000261	CcSEcCtD
Maraviroc—Infection—Methotrexate—rheumatoid arthritis	3.71e-05	0.00026	CcSEcCtD
Maraviroc—Asthenia—Betamethasone—rheumatoid arthritis	3.68e-05	0.000258	CcSEcCtD
Maraviroc—Asthenia—Dexamethasone—rheumatoid arthritis	3.68e-05	0.000258	CcSEcCtD
Maraviroc—Nervous system disorder—Methotrexate—rheumatoid arthritis	3.66e-05	0.000257	CcSEcCtD
Maraviroc—Gastrointestinal pain—Prednisone—rheumatoid arthritis	3.65e-05	0.000256	CcSEcCtD
Maraviroc—Nausea—Prednisolone—rheumatoid arthritis	3.65e-05	0.000256	CcSEcCtD
Maraviroc—Pruritus—Betamethasone—rheumatoid arthritis	3.63e-05	0.000254	CcSEcCtD
Maraviroc—Pruritus—Dexamethasone—rheumatoid arthritis	3.63e-05	0.000254	CcSEcCtD
Maraviroc—Skin disorder—Methotrexate—rheumatoid arthritis	3.63e-05	0.000254	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—LEP—rheumatoid arthritis	3.6e-05	0.000361	CbGpPWpGaD
Maraviroc—Vomiting—Triamcinolone—rheumatoid arthritis	3.59e-05	0.000252	CcSEcCtD
Maraviroc—Vomiting—Methylprednisolone—rheumatoid arthritis	3.59e-05	0.000251	CcSEcCtD
Maraviroc—Nausea—Hydrocortisone—rheumatoid arthritis	3.57e-05	0.00025	CcSEcCtD
Maraviroc—Rash—Triamcinolone—rheumatoid arthritis	3.56e-05	0.00025	CcSEcCtD
Maraviroc—Dermatitis—Triamcinolone—rheumatoid arthritis	3.56e-05	0.00025	CcSEcCtD
Maraviroc—Anorexia—Methotrexate—rheumatoid arthritis	3.56e-05	0.000249	CcSEcCtD
Maraviroc—Rash—Methylprednisolone—rheumatoid arthritis	3.56e-05	0.000249	CcSEcCtD
Maraviroc—Dermatitis—Methylprednisolone—rheumatoid arthritis	3.55e-05	0.000249	CcSEcCtD
Maraviroc—CCR5—Disease—CD4—rheumatoid arthritis	3.54e-05	0.000356	CbGpPWpGaD
Maraviroc—Headache—Triamcinolone—rheumatoid arthritis	3.54e-05	0.000248	CcSEcCtD
Maraviroc—Headache—Methylprednisolone—rheumatoid arthritis	3.53e-05	0.000248	CcSEcCtD
Maraviroc—Body temperature increased—Prednisone—rheumatoid arthritis	3.53e-05	0.000248	CcSEcCtD
Maraviroc—Abdominal pain—Prednisone—rheumatoid arthritis	3.53e-05	0.000248	CcSEcCtD
Maraviroc—CCR5—Disease—PTGS2—rheumatoid arthritis	3.52e-05	0.000354	CbGpPWpGaD
Maraviroc—Diarrhoea—Betamethasone—rheumatoid arthritis	3.51e-05	0.000246	CcSEcCtD
Maraviroc—Diarrhoea—Dexamethasone—rheumatoid arthritis	3.51e-05	0.000246	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	3.4e-05	0.000238	CcSEcCtD
Maraviroc—Dizziness—Dexamethasone—rheumatoid arthritis	3.39e-05	0.000238	CcSEcCtD
Maraviroc—Dizziness—Betamethasone—rheumatoid arthritis	3.39e-05	0.000238	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—FN1—rheumatoid arthritis	3.39e-05	0.000341	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6ST—rheumatoid arthritis	3.38e-05	0.000339	CbGpPWpGaD
Maraviroc—Insomnia—Methotrexate—rheumatoid arthritis	3.38e-05	0.000237	CcSEcCtD
Maraviroc—Nausea—Triamcinolone—rheumatoid arthritis	3.36e-05	0.000235	CcSEcCtD
Maraviroc—Paraesthesia—Methotrexate—rheumatoid arthritis	3.35e-05	0.000235	CcSEcCtD
Maraviroc—Nausea—Methylprednisolone—rheumatoid arthritis	3.35e-05	0.000235	CcSEcCtD
Maraviroc—Hypersensitivity—Prednisone—rheumatoid arthritis	3.29e-05	0.000231	CcSEcCtD
Maraviroc—Vomiting—Betamethasone—rheumatoid arthritis	3.26e-05	0.000229	CcSEcCtD
Maraviroc—Vomiting—Dexamethasone—rheumatoid arthritis	3.26e-05	0.000229	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CD80—rheumatoid arthritis	3.25e-05	0.000327	CbGpPWpGaD
Maraviroc—Decreased appetite—Methotrexate—rheumatoid arthritis	3.25e-05	0.000227	CcSEcCtD
Maraviroc—Rash—Dexamethasone—rheumatoid arthritis	3.23e-05	0.000227	CcSEcCtD
Maraviroc—Rash—Betamethasone—rheumatoid arthritis	3.23e-05	0.000227	CcSEcCtD
Maraviroc—Dermatitis—Dexamethasone—rheumatoid arthritis	3.23e-05	0.000226	CcSEcCtD
Maraviroc—Dermatitis—Betamethasone—rheumatoid arthritis	3.23e-05	0.000226	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	3.22e-05	0.000226	CcSEcCtD
Maraviroc—Fatigue—Methotrexate—rheumatoid arthritis	3.22e-05	0.000226	CcSEcCtD
Maraviroc—Headache—Dexamethasone—rheumatoid arthritis	3.21e-05	0.000225	CcSEcCtD
Maraviroc—Headache—Betamethasone—rheumatoid arthritis	3.21e-05	0.000225	CcSEcCtD
Maraviroc—Asthenia—Prednisone—rheumatoid arthritis	3.21e-05	0.000225	CcSEcCtD
Maraviroc—Pain—Methotrexate—rheumatoid arthritis	3.19e-05	0.000224	CcSEcCtD
Maraviroc—Pruritus—Prednisone—rheumatoid arthritis	3.16e-05	0.000222	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—POMC—rheumatoid arthritis	3.09e-05	0.00031	CbGpPWpGaD
Maraviroc—Diarrhoea—Prednisone—rheumatoid arthritis	3.06e-05	0.000214	CcSEcCtD
Maraviroc—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	3.05e-05	0.000214	CcSEcCtD
Maraviroc—Nausea—Betamethasone—rheumatoid arthritis	3.05e-05	0.000214	CcSEcCtD
Maraviroc—Nausea—Dexamethasone—rheumatoid arthritis	3.05e-05	0.000214	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	3.03e-05	0.000305	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL2—rheumatoid arthritis	3.02e-05	0.000304	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6R—rheumatoid arthritis	3.01e-05	0.000303	CbGpPWpGaD
Maraviroc—Dizziness—Prednisone—rheumatoid arthritis	2.95e-05	0.000207	CcSEcCtD
Maraviroc—Abdominal pain—Methotrexate—rheumatoid arthritis	2.95e-05	0.000207	CcSEcCtD
Maraviroc—Body temperature increased—Methotrexate—rheumatoid arthritis	2.95e-05	0.000207	CcSEcCtD
Maraviroc—Vomiting—Prednisone—rheumatoid arthritis	2.84e-05	0.000199	CcSEcCtD
Maraviroc—Rash—Prednisone—rheumatoid arthritis	2.82e-05	0.000197	CcSEcCtD
Maraviroc—Dermatitis—Prednisone—rheumatoid arthritis	2.81e-05	0.000197	CcSEcCtD
Maraviroc—Headache—Prednisone—rheumatoid arthritis	2.8e-05	0.000196	CcSEcCtD
Maraviroc—Hypersensitivity—Methotrexate—rheumatoid arthritis	2.75e-05	0.000193	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—TYK2—rheumatoid arthritis	2.74e-05	0.000276	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NOS3—rheumatoid arthritis	2.69e-05	0.000271	CbGpPWpGaD
Maraviroc—Asthenia—Methotrexate—rheumatoid arthritis	2.68e-05	0.000188	CcSEcCtD
Maraviroc—Nausea—Prednisone—rheumatoid arthritis	2.65e-05	0.000186	CcSEcCtD
Maraviroc—Pruritus—Methotrexate—rheumatoid arthritis	2.64e-05	0.000185	CcSEcCtD
Maraviroc—Diarrhoea—Methotrexate—rheumatoid arthritis	2.55e-05	0.000179	CcSEcCtD
Maraviroc—CCR5—Disease—TGFB1—rheumatoid arthritis	2.54e-05	0.000256	CbGpPWpGaD
Maraviroc—Dizziness—Methotrexate—rheumatoid arthritis	2.47e-05	0.000173	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CXCL8—rheumatoid arthritis	2.39e-05	0.00024	CbGpPWpGaD
Maraviroc—Vomiting—Methotrexate—rheumatoid arthritis	2.37e-05	0.000166	CcSEcCtD
Maraviroc—Rash—Methotrexate—rheumatoid arthritis	2.35e-05	0.000165	CcSEcCtD
Maraviroc—Dermatitis—Methotrexate—rheumatoid arthritis	2.35e-05	0.000165	CcSEcCtD
Maraviroc—Headache—Methotrexate—rheumatoid arthritis	2.34e-05	0.000164	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IL2—rheumatoid arthritis	2.28e-05	0.00023	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6—rheumatoid arthritis	2.27e-05	0.000228	CbGpPWpGaD
Maraviroc—Nausea—Methotrexate—rheumatoid arthritis	2.22e-05	0.000155	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—MMP9—rheumatoid arthritis	2.16e-05	0.000217	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NFKB1—rheumatoid arthritis	2.14e-05	0.000215	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MAPK8—rheumatoid arthritis	2.1e-05	0.000211	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—VEGFA—rheumatoid arthritis	1.94e-05	0.000195	CbGpPWpGaD
Maraviroc—CCR5—Disease—IL6—rheumatoid arthritis	1.92e-05	0.000193	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	1.9e-05	0.000191	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TGFB1—rheumatoid arthritis	1.78e-05	0.000179	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	1.61e-05	0.000162	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TP53—rheumatoid arthritis	1.47e-05	0.000147	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6—rheumatoid arthritis	1.34e-05	0.000135	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	1.27e-05	0.000127	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	1.22e-05	0.000123	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	1.15e-05	0.000116	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	1.12e-05	0.000113	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GC—rheumatoid arthritis	1.12e-05	0.000113	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	1.04e-05	0.000105	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MED1—rheumatoid arthritis	9.13e-06	9.17e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	8.49e-06	8.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	8.49e-06	8.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—BGN—rheumatoid arthritis	7.64e-06	7.68e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	7.03e-06	7.07e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	5.73e-06	5.76e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CAT—rheumatoid arthritis	4.13e-06	4.15e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	3.44e-06	3.46e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—POMC—rheumatoid arthritis	2.75e-06	2.77e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALB—rheumatoid arthritis	2.51e-06	2.52e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	2.4e-06	2.41e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	2.2e-06	2.21e-05	CbGpPWpGaD
